Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sigma HealthcareASX:SIG -0.67%55 EV-to-EBITDA is 56.72 as of Jul. 30, 2026, which is 213% above its 10-year median of 18.13. GuruFocus rates ASX:SIG with a GF Score™ of 55/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 98 Medical Distribution companies, Sigma Healthcare ranks worse than 96.94% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sigma Healthcare's enterprise value is A$36,233 Mil.
Sigma Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$639 Mil. Therefore, Sigma Healthcare's EV-to-EBITDA for today is 56.72.
The historical rank and industry rank for Sigma Healthcare's EV-to-EBITDA or its related term are showing as below:
ASX:SIG'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.34 Med: 18.13 Max: 94.22
Current: 56.72
During the past 13 years, the highest EV-to-EBITDA of Sigma Healthcare was 94.22. The lowest was 6.34. And the median was 18.13.
ASX:SIG's EV-to-EBITDA is ranked worse than 96.94% of 98
companies
in the Medical Distribution industry
Industry Median: 8.675
vs ASX:SIG: 56.72
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sigma Healthcare's PE Ratio (TTM) for today is calculated as:
Sigma Healthcare's share price for today is A$2.96.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sigma Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.022.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Sigma Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Sigma Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sigma Healthcare EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Sigma Healthcare's EV-to-EBITDA falls into.
Sigma Healthcare's current Enterprise Value is A$36,233 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sigma Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$639 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sigma Healthcare (ASX:SIG) has a EV-to-EBITDA of 56.72 as of Jul. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Sigma Healthcare. This is 213% above median its historical median of 18.13. Over the past decade, Sigma Healthcare's EV-to-EBITDA has ranged from 6.34 to 94.22. According to the industry distribution chart, Sigma Healthcare ranks #95 out of 98 companies in the Medical Distribution industry, placing it in the top 96.9%.
Is Sigma Healthcare's EV-to-EBITDA too high?
Sigma Healthcare's current EV-to-EBITDA of 56.72 is 213% above median its 10-year median of 18.13. Over the past 10 years, this metric has ranged from a low of 6.34 to a high of 94.22. The Medical Distribution industry median EV-to-EBITDA is 8.68. Sigma Healthcare's value of 56.72 is 553.8% above this industry median. Based on the distribution chart, Sigma Healthcare ranks #95 out of 98 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Sigma Healthcare has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's EV-to-EBITDA compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sigma Healthcare ranks #95 out of 98 companies for EV-to-EBITDA. This places Sigma Healthcare in the lower half of its industry. The industry median EV-to-EBITDA is 8.68. Sigma Healthcare's value of 56.72 is 553.8% above this benchmark. Historically, Sigma Healthcare's own EV-to-EBITDA has ranged from 6.34 to 94.22 over the past decade. While the company's 10-year median is 18.13 vs. the industry median of 8.68, Sigma Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.68, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sigma Healthcare's current EV-to-EBITDA of 56.72 is 553.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Sigma Healthcare. For the Medical Distribution industry, the median EV-to-EBITDA is 8.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sigma Healthcare's current EV-to-EBITDA is 56.72, which is 213% above median its own 10-year median of 18.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.96 — trading 700% above its estimated fair value. The current EV-to-EBITDA is 56.72, which is 213% above median its 10-year median of 18.13 and 553.8% above the Medical Distribution industry median of 8.68. Sigma Healthcare's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current EV-to-EBITDA is 56.72 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?
Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued.
The current stock price of A$2.96 is trading 700% above its estimated GF Value™ of A$0.37.
GuruFocus considers Sigma Healthcare to be Significantly Overvalued.
Key valuation signals for ASX:SIG:
EV-to-EBITDA: 56.72 (213% above median its 10-year median of 18.13)
GF Value™: A$0.37 vs. price of A$2.96 (700% above fair value)
Industry Position: 553.8% above the Medical Distribution median (#95 of 98)
No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
55GF Score
Get the complete analysis for ASX:SIG
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SIG has been successfully added to your 
